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Background
Congenital toxoplasmosis usually results from acquired
infection in non-immune pregnant woman. Some cases
have been described in immunodeficient women, as a
result of Toxoplasma gondii infection reactivation [1-3]. We
report the case of a fetal death probably related to a con-
genital toxoplasmosis in an HIV infected pregnant
woman during immune restoration following HAART ini-
tiation.
Case report
An HIV infection was diagnosed in a 26 years old African
pregnant woman at 10 weeks of pregnancy. The CD4 cell
count was 7/µl (1%), the HIV viral load was 108,000 cp/
ml, and the toxoplasmic serology was positive for IgG
(18000 UI/ml) and IgM negative, the retrospective toxo-
plasma detection by PCR was negative at entry.
HAART consisting in a combination of lopinavir/r and
zidovudine plus lamivudine was introduced at 12 weeks
of pregnancy resulting in a rapid immune restoration 2
weeks later: At that time the CD4 cell count increased up
to 185/µl (10%) and the plasmatic HIV viral load
dropped to 1,222 cp/ml.
A miscarriage occured 7 weeks after HAART introduction.
At this time, toxoplasma PCR was positive in the mother
plasma as well as in the amniotic fluid, concomitantly
with an anti toxoplasma IgG increase (81,000 UI/ml) and
occurrence of anti toxoplasma IgM, amniotic fluid HIV
viral load was undetectable. The post-mortem analysis
dated the foetus death around16 weeks of pregnancy that
was 4 weeks after the HAART introduction and showed
evidence of non specific inflammatory histologic lesions.
Conclusions
The chronological parallelism between toxoplasmosis
reactivation and rapid CD4 cell count increase makes us
wonder if this miscarriage case could not be an immune
reconstitution inflammatory syndrome manifestation
associated with toxoplasmosis reactivation. According to
this hypothesis, we should take into account IRIS risk fac-
tors in HIV infected pregnant woman when introducing
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HAART, not only for the mother but also for a healthy foe-
tal development.
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